GL1X · GenesisL1 explorer

Research workbench

Human EPHA3 kinase domain in complex with quinoxaline derivatives

Analyse Human EPHA3 kinase domain in complex with quinoxaline derivatives in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4P4C
Type
protein
Length
266 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Eph receptor A3
EC
2.7.10.1
UniProt
Q6P4R6
Ligands
25Q
Pockets
2 · best druggability 0.59

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEph receptor A3 (EC 2.7.10.1)protein26642% helix, 19% strandQ6P4R6

Ligands and binding sites

  • 25Q · 2-amino-1-(3-methoxyphenyl)-1H-pyrrolo[2,3-b]quinoxaline-3-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12400.590.792725Q
2500.270.7414empty

Compared structures

  • 4P4C · Human EphA3 Kinase domain in complex with quinoxaline derivatives · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.